A pharmaceutical formulation of the cannabis extract, cannabidiol is being developed for those patients who do not respond to previous treatments for seizures associated with Lennox-Gastaut syndrome. This is taken as an oral solution.
A pharmaceutical formulation of the cannabis extract, cannabidiol is being developed for those patients who do not respond to previous treatments for seizures associated with Lennox-Gastaut syndrome. This is taken as an oral solution.